13 results

• Class Action Lawsuit Over EpiPen Pricing, Kickbacks Allowed to Proceed

  January 25, 2021

  Irvin Jackson

  Mylan must face a class action lawsuit over claims of price-fixing and bribery after a federal judge refused to dismiss their claims.

• Generic EpiPens May Malfunction, Deliver Double Dose, FDA Warns

  June 4, 2020

  Russell Maas

  The FDA warns that some generic EpiPens may deliver an overdose of epinephrine due to a missing component.

• EpiPen Problems May Lead To Premature Device Activation, FDA Warns

  March 26, 2020

  Russell Maas

  Mylan and the FDA warn that EpiPens may go off prematurely if they experience sideways pressure, and in some cases may become stuck in their carriers.

• EpiPen Auto-Injectors May Get Stuck In Carrier Tube, FDA Warns

  November 5, 2018

  Irvin Jackson

  Mylan and the FDA warn that some EpiPen and EpiPen Jr. Auto-Injectors may jam due to problems with the label, preventing potentially life-saving epinephrine during a severe allergic reaction.

• Use of Epinephrine To Save Cardiac Arrest Patients May Carry Neurological Risks: Study

  September 5, 2018

  Irvin Jackson

  A new study indicates epinephrine use increased the risk of surviving cardiac arrest, but also appeared to increase the risk of neurologic damage among survivors.

• Allergy-Related Visits To ER Increasing Among U.S. Children: Study

  March 16, 2018

  Martha Garcia

  A new report warns that an increasing number of children are visiting emergency rooms nationwide due to allergic reactions and anaphylactic shock.

• EpiPen Failures Caused At Least Seven Deaths This Year, According to FDA Data

  November 3, 2017

  Irvin Jackson

  The FDA received more than 200 reports of EpiPen failures this year by mid-September, including seven reports of consumer deaths, according to a Freedom of Information Act request.

• EpiPen Malfunction Problems Involving Deaths, Severe Injuries Not Properly Investigated by Manufacturer: FDA

  September 13, 2017

  Irvin Jackson

  The FDA has issued a warning letter to the manufacturers of the EpiPen, indicating that they ignored complaints of malfunctions and should have issued an EpiPen recall.

• JPML Centralizes EpiPen Pricing Lawsuits In MDL For Pretrial Proceedings

  August 10, 2017

  Irvin Jackson

  All EpiPen pricing lawsuits have been consolidated before one judge who will oversee pretrial proceedings and class action certification for claims that the company is unfairly dominating the epinephrine injector market and overcharging consumers.

• EpiPens Not Getting To Children That Need Them: Study

  July 14, 2017

  Martha Garcia

  A new study reveals that most children who need an EpiPen injection due to a severe allergic reaction are not receiving them, resulting in longer hospital stays.